Entities / Company
Bio-Rad Laboratories.
American life science research firm
- Reports this week
- 0
- Active events
- 2
- Connections
- 62
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.Some support1 report1 development inside
-
Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.Some support1 report
Earlier this month
One to three months ago
-
Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.Some support1 report2 developments inside
-
Illumina and Bio-Rad Laboratories collaborate on advanced life science technologies.Some support1 report1 development inside
-
RBC lifted its price objective for Bio-Rad Laboratories, and Citigroup also raised its price objective for the company.Some support3 reports
-
Bio-Rad Laboratories reported sales growth in the Americas, while the NIH noted rising funding but lagging purchasing.Some support1 report
-
Bio-Rad Laboratories reported that its sales in China fell significantly in the high teens.Some support1 report
Gone quiet
No new reports in 90+ days-
GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.Some support1 report
-
A test highlighting value in personalized medicine is mentioned in a competitive market assessment involving Roche, Bio-Rad, and Charles River.Some support3 reports
-
Bio-Rad Laboratories is headquartered in Hercules, California.Some support3 reports
-
Phibro Animal Health's acquisition strengthens its ddPCR offering and expands into new markets.Some support1 report
-
Trump's pledge to unleash oil and gas benefits stocks, specifically involving Bio-Rad Laboratories.Some support1 report
-
Jim Barry joined Bio-Rad Laboratories on July 7, 2025, serving as EVP and President of the company's Life Science Group.Speculative1 report
-
Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.Some support1 report
-
Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.Some support1 report1 development inside
-
Saudi Arabia is a key region for the HPV testing market, with growth driven by diagnostic technology advancements from companies like Qiagen and Bio-Rad.Some support1 report
-
Mehta was appointed EVP Global Commercial Operations at Bio-Rad, while Crowley retired, and Mehta's past roles at Dow Chemical were noted.Some support1 report
-
Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.Some support1 report
-
Bio-Rad Laboratories acquired Stilla Technologies and Norman Schwartz was appointed as Chairman and CEO.Some support2 reports
-
Market growth in the STD Diagnostic Market is being driven by technological advancements and increased STD prevalence.Some support1 report
-
Bio-Rad Laboratories' stock performance was compared against the Russell 2000 Index and HFRX Equity Hedge Index in September 2025.Some support1 report
-
The event mentions George Joseph as founder of Mercury, Alice Schwartz founding Bio-Rad, and groups Elon Musk and Mark Zuckerberg among young tech billionaires.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Bio-Rad Laboratories this week
News at the entities that move Bio-Rad Laboratories most-
Citigroup Mentioned togetherCitigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Moves Bio-Rad Laboratories
-
Royal Bank of Canada Mentioned togetherRoyal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Moves Bio-Rad Laboratories
-
National Institutes of Health TransactionalPDS Biotechnology and the National Cancer Institute entered into a collaborative R&D agreement.Moves Bio-Rad Laboratories
-
Charles River Laboratories OperationalApollo is the digital client engagement platform for Charles River Laboratories, and Mark Mintz serves as CIO and head of global shared services.Moves Bio-Rad Laboratories
-
Illumina OperationalAnalysis suggests that both Moderna and Illumina stocks are currently overvalued.Moves Bio-Rad Laboratories
-
China Shared contextThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Bio-Rad Laboratories
Connections
The 10 strongest of 62, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Royal Bank of Canada Mentioned together
RBC published a market analysis that raised its price objective for Bio-Rad Laboratories.
-
SEC Structural
Bio-Rad Laboratories is required to file regulatory reports, such as 13F filings, with the SEC to operate in the market.
-
Charles River Laboratories Operational
Both companies are described as competitors occupying vital positions within the biotech supply chain.
-
Illumina Operational
The companies collaborate on advanced life science technologies.
-
National Institutes of Health Transactional
NIH is noted as a potential purchaser of goods and services from Bio-Rad Laboratories.
-
Citigroup Mentioned together
Citigroup published research reports indicating raises to its price objective and target for Bio-Rad Laboratories.
-
Hercules Shared context
Bio-Rad Laboratories is headquartered in Hercules, California.
-
China Shared context
Bio-Rad Laboratories operates within the Chinese market context, where sales performance is tracked.
History
Events by the month they beganSeptember 2026
3 events- Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.
- Bio-Rad Laboratories filed its required 13F reports with the SEC on September 7, 2026.
- Bio-Rad Laboratories and BioLife Solutions, Inc. are life science companies that develop products marketed in the Middle East, Europe, and the US.
August 2026
4 events- Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.
- RBC lifted its price objective for Bio-Rad Laboratories, and Citigroup also raised its price objective for the company.
- Bio-Rad Laboratories reported sales growth in the Americas, while the NIH noted rising funding but lagging purchasing.
- Bio-Rad Laboratories reported that its sales in China fell significantly in the high teens.
July 2026
1 eventShow 1 earlier month
June 2026
16 events- Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.
- GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.
- A test highlighting value in personalized medicine is mentioned in a competitive market assessment involving Roche, Bio-Rad, and Charles River.
- Bio-Rad Laboratories is headquartered in Hercules, California.
- Phibro Animal Health's acquisition strengthens its ddPCR offering and expands into new markets.
- Trump's pledge to unleash oil and gas benefits stocks, specifically involving Bio-Rad Laboratories.
- Jim Barry joined Bio-Rad Laboratories on July 7, 2025, serving as EVP and President of the company's Life Science Group.
- Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.
- Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.
- Saudi Arabia is a key region for the HPV testing market, with growth driven by diagnostic technology advancements from companies like Qiagen and Bio-Rad.
- Mehta was appointed EVP Global Commercial Operations at Bio-Rad, while Crowley retired, and Mehta's past roles at Dow Chemical were noted.
- Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.
- Bio-Rad Laboratories acquired Stilla Technologies and Norman Schwartz was appointed as Chairman and CEO.
- Market growth in the STD Diagnostic Market is being driven by technological advancements and increased STD prevalence.
- Bio-Rad Laboratories' stock performance was compared against the Russell 2000 Index and HFRX Equity Hedge Index in September 2025.
- The event mentions George Joseph as founder of Mercury, Alice Schwartz founding Bio-Rad, and groups Elon Musk and Mark Zuckerberg among young tech billionaires.